Product Information

SAXAGLIPTIN HCL 5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.1086 per EA under NDC 68462072790. Its NADAC has been published 162 times since Oct 18, 2023.

FDA first approved this application on Jul 31, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SAXAGLIPTIN HCL 5 MG TABLET

SAXAGLIPTIN
$1.1086per EA

Strength

5 mg/1

NDC

68462072790

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SAXAGLIPTIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA205994

FDA Approved

7/31/2023

TE Code

AB

On Market Since

7/31/2023

Pharmacological Classes

Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitors

Price Statistics

The NADAC for SAXAGLIPTIN HCL 5 MG TABLET has been published 162 times since Oct 18, 2023, and over the history we have for it it has declined 31.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1086 per EA
All-time high$6.6735 (Jun 12, 2024)
All-time low$1.0387 (Sep 23, 2026)
52-week high$2.9076
52-week low$1.0387
Median price$3.2935
Average price$3.3310
Largest weekly change+315.1% (Apr 17, 2024)
Weeks tracked162
Tracking sinceOct 18, 2023

Price History

1W

+3.8%

1M

+6.7%

3M

+5.6%

6M

-2.9%

1Y

-61.9%

3Y

-31.9%

5Y

N/A

All

-31.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SAXAGLIPTIN HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN HCL 5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.1086 per EA (NDC 68462072790), effective Nov 18, 2026.

How has the price of SAXAGLIPTIN HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has declined 31.9%. It has been tracked across 162 weekly CMS publications since Oct 18, 2023.

What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN HCL 5 MG TABLET?

Since Oct 18, 2023, the NADAC for SAXAGLIPTIN HCL 5 MG TABLET has ranged from a low of $1.0387 (Sep 23, 2026) to a high of $6.6735 (Jun 12, 2024), with a median of $3.2935 per EA.

Are there cheaper alternatives to SAXAGLIPTIN HCL 5 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SAXAGLIPTIN HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures SAXAGLIPTIN HCL 5 MG TABLET?

SAXAGLIPTIN HCL 5 MG TABLET (NDC 68462072790) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.